MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617091230 A) filed by Newamsterdam Pharma B. V. on July 27, 2026, for Pharmaceutical Compositions Of Obicetrapib.
Inventors include Cui, Sheng; Craig, Joanne Lesley; Kastelein, Johannes Jacob Pieter; Ditmarsch, Marc; Davidson, Michael Harvey; Rtheli, Andreas Ren; Borths, Christopher J.; Kishida, Muneki; and Smolenskaya, Valeriya Nikolayevna.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Provided herein are pharmaceutical compositions comprising obicetrapib, or a pharmaceutically acceptable salt, solvate or co-crystal thereof, including, for example, obicetrapib calcium, obicetrapib calcium which, as used herein, is obicetrapib hemicalcium, and which may, in many embodiments, be amorphous obicetrapib hemicalcium; and optionally one or more additional pharmaceutically acceptable excipients. Also provided are pharmaceutical dosage forms including the same processes for making such pharmaceutical compositions, and methods for using such pharmaceutical compositions in the treatment of subjects including in treatments requiring reduction in LDL cholesterol and/or an increase in HDL cholesterol and other ailments.
Disclaimer: Curated by HT Syndication.
